11.93
price up icon3.38%   0.39
after-market Handel nachbörslich: 11.93
loading
Schlusskurs vom Vortag:
$11.54
Offen:
$11.35
24-Stunden-Volumen:
2.47M
Relative Volume:
1.23
Marktkapitalisierung:
$967.13M
Einnahmen:
$139.71M
Nettoeinkommen (Verlust:
$-209.36M
KGV:
-4.0304
EPS:
-2.96
Netto-Cashflow:
$-160.60M
1W Leistung:
+6.14%
1M Leistung:
-12.98%
6M Leistung:
-38.91%
1J Leistung:
-42.64%
1-Tages-Spanne:
Value
$11.20
$12.48
1-Wochen-Bereich:
Value
$10.81
$12.48
52-Wochen-Spanne:
Value
$9.66
$25.07

Syndax Pharmaceuticals Inc Stock (SNDX) Company Profile

Name
Firmenname
Syndax Pharmaceuticals Inc
Name
Telefon
781-419-1400
Name
Adresse
35 GATEHOUSE DRIVE, WALTHAM, MA
Name
Mitarbeiter
184
Name
Twitter
@syndax
Name
Nächster Verdiensttermin
2025-03-03
Name
Neueste SEC-Einreichungen
Name
SNDX's Discussions on Twitter

Vergleichen Sie SNDX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
SNDX
Syndax Pharmaceuticals Inc
11.93 967.13M 139.71M -209.36M -160.60M -2.96
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
477.52 127.47B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
561.49 62.43B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
595.70 37.03B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
232.75 31.06B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
229.22 26.16B 3.81B -644.79M -669.77M -6.24

Syndax Pharmaceuticals Inc Stock (SNDX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-10-24 Eingeleitet UBS Buy
2024-06-28 Eingeleitet Jefferies Buy
2024-01-31 Herabstufung Scotiabank Sector Outperform → Sector Perform
2023-12-22 Eingeleitet Mizuho Buy
2023-10-25 Eingeleitet BofA Securities Buy
2023-10-11 Eingeleitet Goldman Buy
2023-07-27 Eingeleitet Scotiabank Sector Outperform
2023-07-11 Eingeleitet Guggenheim Buy
2023-04-17 Fortgesetzt BTIG Research Buy
2023-01-31 Eingeleitet Stifel Buy
2023-01-03 Eingeleitet JP Morgan Overweight
2022-07-28 Fortgesetzt B. Riley Securities Buy
2022-04-11 Eingeleitet H.C. Wainwright Buy
2022-02-15 Eingeleitet Goldman Buy
2021-06-04 Fortgesetzt Robert W. Baird Outperform
2021-05-25 Eingeleitet Citigroup Buy
2021-02-18 Eingeleitet B. Riley Securities Buy
2020-12-03 Eingeleitet Stifel Buy
2020-05-22 Hochstufung Citigroup Neutral → Buy
2020-05-22 Herabstufung H.C. Wainwright Buy → Neutral
2020-05-18 Herabstufung Citigroup Buy → Neutral
2020-05-11 Bestätigt H.C. Wainwright Buy
2020-03-04 Eingeleitet Barclays Overweight
2020-01-13 Bestätigt H.C. Wainwright Buy
2019-03-08 Bestätigt H.C. Wainwright Buy
2019-01-04 Eingeleitet Robert W. Baird Outperform
2018-01-05 Eingeleitet B. Riley FBR, Inc. Buy
2017-03-16 Eingeleitet FBR & Co. Outperform
2017-03-02 Eingeleitet Instinet Buy
2016-10-07 Eingeleitet Guggenheim Buy
2016-03-28 Eingeleitet Citigroup Buy
2016-03-28 Eingeleitet JMP Securities Mkt Outperform
2016-03-28 Eingeleitet Morgan Stanley Overweight
Alle ansehen

Syndax Pharmaceuticals Inc Aktie (SNDX) Neueste Nachrichten

pulisher
05:19 AM

Jump Financial LLC Grows Stake in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat

05:19 AM
pulisher
Apr 20, 2025

Altium Capital Management LLC Makes New $4.89 Million Investment in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat

Apr 20, 2025
pulisher
Apr 20, 2025

Renaissance Technologies LLC Makes New $9 Million Investment in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat

Apr 20, 2025
pulisher
Apr 19, 2025

Walleye Capital LLC Has $4.82 Million Stock Position in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat

Apr 19, 2025
pulisher
Apr 19, 2025

(SNDX) On The My Stocks Page - news.stocktradersdaily.com

Apr 19, 2025
pulisher
Apr 18, 2025

Sei Investments Co. Lowers Position in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat

Apr 18, 2025
pulisher
Apr 15, 2025

StockNews.com Upgrades Syndax Pharmaceuticals (NASDAQ:SNDX) to "Sell" - MarketBeat

Apr 15, 2025
pulisher
Apr 14, 2025

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Shares Sold by ExodusPoint Capital Management LP - MarketBeat

Apr 14, 2025
pulisher
Apr 14, 2025

Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Price Down 6.6%Here's What Happened - MarketBeat

Apr 14, 2025
pulisher
Apr 13, 2025

Syndax Pharmaceuticals (NASDAQ:SNDX) Reaches New 52-Week LowHere's Why - MarketBeat

Apr 13, 2025
pulisher
Apr 12, 2025

Sei Investments Co. Sells 35,414 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - Defense World

Apr 12, 2025
pulisher
Apr 11, 2025

Barclays Adjusts Price Target for Syndax (SNDX) Ahead of Q1 Earnings | SNDX Stock News - GuruFocus

Apr 11, 2025
pulisher
Apr 11, 2025

Vanguard Group Inc. Sells 5,006 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - Defense World

Apr 11, 2025
pulisher
Apr 11, 2025

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Apr 11, 2025
pulisher
Apr 10, 2025

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Shares Sold by Rhenman & Partners Asset Management AB - MarketBeat

Apr 10, 2025
pulisher
Apr 10, 2025

Trexquant Investment LP Buys 437,859 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat

Apr 10, 2025
pulisher
Apr 10, 2025

Bryce Point Capital LLC Makes New Investment in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat

Apr 10, 2025
pulisher
Apr 10, 2025

Syndax Pharmaceuticals (NASDAQ:SNDX) Raised to “Sell” at StockNews.com - Defense World

Apr 10, 2025
pulisher
Apr 09, 2025

SNDX stock touches 52-week low at $10.14 amid market challenges By Investing.com - Investing.com South Africa

Apr 09, 2025
pulisher
Apr 09, 2025

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Shares Sold by Wellington Management Group LLP - MarketBeat

Apr 09, 2025
pulisher
Apr 09, 2025

Syndax Announces Participation at the Stifel 2025 Virtual Targeted Oncology Forum - The Globe and Mail

Apr 09, 2025
pulisher
Apr 09, 2025

Syndax at Stifel Forum: Strategic Drug Launches By Investing.com - Investing.com Canada

Apr 09, 2025
pulisher
Apr 08, 2025

Corebridge Financial Inc. Has $540,000 Stock Holdings in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - Defense World

Apr 08, 2025
pulisher
Apr 08, 2025

KLP Kapitalforvaltning AS Acquires New Stake in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - Defense World

Apr 08, 2025
pulisher
Apr 07, 2025

Syndax Pharmaceuticals: Down But Not Out (NASDAQ:SNDX) - Seeking Alpha

Apr 07, 2025
pulisher
Apr 07, 2025

Syndax Pharmaceuticals (NASDAQ:SNDX) Trading 4.7% HigherStill a Buy? - MarketBeat

Apr 07, 2025
pulisher
Apr 07, 2025

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World

Apr 07, 2025
pulisher
Apr 06, 2025

Syndax Pharmaceuticals (NASDAQ:SNDX) Rating Increased to Sell at StockNews.com - MarketBeat

Apr 06, 2025
pulisher
Apr 06, 2025

Axiom Investors LLC DE Sells 62,418 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat

Apr 06, 2025
pulisher
Apr 05, 2025

Syndax Pharmaceuticals (NASDAQ:SNDX) Sets New 12-Month LowWhat's Next? - MarketBeat

Apr 05, 2025
pulisher
Apr 05, 2025

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - The Manila Times

Apr 05, 2025
pulisher
Apr 04, 2025

Syndax Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - marketscreener.com

Apr 04, 2025
pulisher
Apr 04, 2025

Syndax Pharmaceuticals (NASDAQ:SNDX) Trading Down 7.5%Here's Why - MarketBeat

Apr 04, 2025
pulisher
Apr 02, 2025

How the (SNDX) price action is used to our Advantage - news.stocktradersdaily.com

Apr 02, 2025

Finanzdaten der Syndax Pharmaceuticals Inc-Aktie (SNDX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.07
price up icon 0.15%
$69.51
price down icon 4.32%
$32.19
price down icon 1.26%
$25.22
price up icon 2.48%
$101.81
price up icon 3.09%
biotechnology ONC
$229.22
price down icon 0.76%
Kapitalisierung:     |  Volumen (24h):